Evidence map›Paper›PMID 31396168›Full record

ArticleFrontiers in microbiology2019

Identification of Potential Virulence Factors in the Model Strain

Maria S Ramirez, William F Penwell, German M Traglia, Daniel L Zimbler, Jennifer A Gaddy, Nikolas Nikolaidis, Brock A Arivett, Mark D Adams, Robert A Bonomo, Luis A Actis and 1 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Whole-genome sequencing ofMicrobial genomics · 2025
    Article
  3. Article
  4. Insights intoInternational journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Biology · 2022
    Article
  11. Article
  12. Subunit vaccines forFrontiers in immunology · 2022
    Review
  13. Article
  14. Pathogens (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Pathogens (Basel, Switzerland) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria S RamirezDepartment of Biological Science, Center for Applied Biotechnology Studies, California State University, Fullerton, Fullerton, CA, United States.
William F PenwellDepartment of Microbiology, Miami University, Oxford, OH, United States.
German M TragliaLaboratorio de Bacteriología Clínica, Departamento de Bioquímica Clínica, Facultad de Farmacia y Bioquímica, Hospital de Clínicas "José de San Martín", Buenos Aires, Argentina.
Daniel L ZimblerDepartment of Microbiology, Miami University, Oxford, OH, United States.
Jennifer A GaddyDepartment of Microbiology, Miami University, Oxford, OH, United States.
Nikolas NikolaidisDepartment of Biological Science, Center for Applied Biotechnology Studies, California State University, Fullerton, Fullerton, CA, United States.
Brock A ArivettDepartment of Microbiology, Miami University, Oxford, OH, United States.
Mark D AdamsDepartment of Genetics, School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
Robert A BonomoDepartments of Pharmacology and Molecular Biology and Microbiology, Louis Stokes Cleveland Veterans Affairs Medical Center, School of Medicine, Case Western Reserve University, Cleveland, OH, United States.
Luis A ActisDepartment of Microbiology, Miami University, Oxford, OH, United States.
Marcelo E TolmaskyDepartment of Biological Science, Center for Applied Biotechnology Studies, California State University, Fullerton, Fullerton, CA, United States.

Funding

Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
DEALING WITH ANTIBIOTIC RESISTANCE--ANTISENSE TECHNOLOGYR15AI047115 · NIAID · CALIFORNIA STATE UNIVERSITY FULLERTON · PI TOLMASKY, MARCELO E · 2000 to 2022
$1.8M
Study of iron acquisition in Acinetobacter baumanniiR01AI070174 · NIAID · MIAMI UNIVERSITY OXFORD · PI ACTIS, LUIS A · 2007 to 2011
$1.4M
Identifying host human products responsible for natural transformation of resistance traits in Acinetobacter sppSC3GM125556 · NIGMS · CALIFORNIA STATE UNIVERSITY FULLERTON · PI RAMIREZ, MARIA SOLEDAD · 2018 to 2025
$851k
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–
BLRD VA I01 BX001974NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI070174NIAID NIH HHS R01 AI072219NIAID NIH HHS R15 AI047115NIGMS NIH HHS SC3 GM125556
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobactercommunity infectionESKAPEhospital infectionpathogenicityvirulence factors

Identifiers

PMID31396168
PMCPMC6663985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.